Company Insider Tape

Tyra Biosciences Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol TYRA Latest filing 28 May 2026

Company Read

Acquisition-led

TYRA has 18 stored insider filings. Acquisitions account for 100.0% of classified filings and disposals account for 0.0%.

Latest filing 28 May 2026most recent stored row
Largest filing $0reported transaction value
Total filings 18stored transaction rows
Acquisition value $018 acquisitions
Disposal value $00 disposals
Net value $0acquisitions minus disposals

Filing cadence

Last 12 active months
Apr 2026 1
May 2026 17

Acquisitions 100.0% · Disposals 0.0%

Apr 2026 $0
May 2026 $0

Executive concentration

By filing count
ASHAR, BHAVESH Chief Operating Officer · 2 filings
FUHRMAN, ALAN Chief Financial Officer · 2 filings
HARRIS, TODD Director, President and CEO · 2 filings
RUEB, YULIYA Vice President, Finance (PAO) · 2 filings
WARNER, DOUGLAS J Chief Medical Officer · 2 filings
MORAN, SUSAN Director · 1 filings
MORE, ROBERT J Director · 1 filings
RA, CAPITAL MANAGEMENT, L.P. Director, 10% Owner · 1 filings

Market Context

TYRA weekly market snapshot

Week 31 Jul 2026
Latest close 31.88 USDstored weekly close
1-week move +4.1%latest weekly bar
13-week move +4.1%medium-term context
Relative Strength 14.1Sharemaestro indicator
Fair value gap +70.6%price vs fair value
Trend signal 0smoothed trend state

Transaction History

Latest insider filings for TYRA

Showing 1-18 of 18
Date 28 May 2026
Insider GULFO, ADELE M.Director
Side Acquisition
Shares 13160
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 28 May 2026
Insider MORAN, SUSANDirector
Side Acquisition
Shares 13160
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 28 May 2026
Insider MORE, ROBERT JDirector
Side Acquisition
Shares 13160
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 28 May 2026
Insider RA, CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Side Acquisition
Shares 13160
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 28 May 2026
Insider ROTHENBERG, STEPHEN MICHAELDirector
Side Acquisition
Shares 13160
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 28 May 2026
Insider SIMSON, JAKEDirector
Side Acquisition
Shares 13160
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 28 May 2026
Insider VERJEE, REHANDirector
Side Acquisition
Shares 13160
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 5 May 2026
Insider ASHAR, BHAVESHChief Operating Officer
Side Acquisition
Shares 15013
Price 0.00
Value 0
Security Common Stock
Date 5 May 2026
Insider ASHAR, BHAVESHChief Operating Officer
Side Acquisition
Shares 50295
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 5 May 2026
Insider FUHRMAN, ALANChief Financial Officer
Side Acquisition
Shares 20000
Price 0.00
Value 0
Security Common Stock
Date 5 May 2026
Insider FUHRMAN, ALANChief Financial Officer
Side Acquisition
Shares 67000
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 5 May 2026
Insider HARRIS, TODDDirector, President and CEO
Side Acquisition
Shares 265000
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 5 May 2026
Insider HARRIS, TODDDirector, President and CEO
Side Acquisition
Shares 79000
Price 0.00
Value 0
Security Common Stock
Date 5 May 2026
Insider RUEB, YULIYAVice President, Finance (PAO)
Side Acquisition
Shares 8333
Price 0.00
Value 0
Security Common Stock
Date 5 May 2026
Insider RUEB, YULIYAVice President, Finance (PAO)
Side Acquisition
Shares 28000
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 5 May 2026
Insider WARNER, DOUGLAS JChief Medical Officer
Side Acquisition
Shares 25000
Price 0.00
Value 0
Security Common Stock
Date 5 May 2026
Insider WARNER, DOUGLAS JChief Medical Officer
Side Acquisition
Shares 85000
Price 0.00
Value 0
Security Stock Option (Right to Buy)
Date 16 Apr 2026
Insider DABLE, HABIB JDirector
Side Acquisition
Shares 44400
Price 0.00
Value 0
Security Stock Option (Right to Buy)